# FDA Inspection 1066200 - MD Tox Laboratory - July 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/md-tox-laboratory/0887734a-676d-4610-bf4d-f4bc60cc2c66
Source feed: FDA_Inspections

> FDA Inspection 1066200 for MD Tox Laboratory on July 11, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066200
- Company Name: MD Tox Laboratory
- Inspection Date: 2018-07-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1259404 - 2025-01-28](https://www.keypedia.com/records/fda_inspections/md-tox-laboratory/ce8917f3-0e5c-48d6-b375-f87bcef09347)
- [FDA Inspection 1210547 - 2023-07-20](https://www.keypedia.com/records/fda_inspections/md-tox-laboratory/a2e28a2c-4197-45a0-aed5-d3454a901e77)

Company: https://www.keypedia.com/companies/md-tox-laboratory/9edf7a0f-fe33-4fe0-8347-af9e3fb1af1c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d